Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for trypsin inhibitor de- 3
Most Correlated Studies
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Most Relevant Literature
- Canonical or noncanonical? Structural plasticity of serine protease-binding loops in Kunitz-STI prot…
- Gastrobodies are engineered antibody mimetics resilient to pepsin and hydrochloric acid.
- Ultrasound-enhanced interfacial adsorption and inactivation of soy trypsin inhibitors.
- Targeted inactivation of soybean proteinase inhibitors using zinc.
- Development of Breeder-Friendly KASP Markers for Low Concentration of Kunitz Trypsin Inhibitor in So…
Most Relevant Clinical Trials
- In Vivo Effects of Amylase Trypsin Inhibitors
- Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COP…
- Effect of Mepolizumab on Severe Eosinophilic Asthma
- Efficacy and Safety of Ovotransferrin in COVID-19 Patients
- Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea
